Project Grant R01AI187088
Award Date
11/22/24
Completion Date
10/31/29
Dollars Obligated
$723K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
Rochester, NY 14642, USA
Similar Awards
This $252,280 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) will fund research to evaluate the role of monocyte cells in the development of an effective HIV vaccine response. The research project aims to investigate changes in monocyte gene expression following HIV infection, autoimmune disease, and vaccination, and to identify monocyte subtypes associated with antibody...
This federal Project Grant award, totaling $472,210.00, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to investigate the spatiotemporal relationship between CD4+ T resident memory cells and neutrophil recruitment in the lungs during pneumonia, while developing a transcriptional atlas of immune processes in the experienced lung. Key objectives include...
This Project Grant award, valued at $792,687.00 and issued by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to define the structural features of sialoglycans necessary for influenza A virus (IAV) infection and adaptation across various host species. The key activities under this award include: 1) using CRISPR/Cas9 techniques to truncate different types of sialoglycans in human lung...
This federal Project Grant award of $586,250 from the National Institute of Allergy and Infectious Diseases (NIAID) under CFDA 93.855 Allergy and Infectious Diseases Research program supports research to investigate how distinct age-associated B cell subsets can protect the aged from influenza. The project aims to determine the potential of different age-associated B cell subsets to respond to influenza infection and generate antibody-secreting cells, B cell memory, and long-lived...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $404,539 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Rochester General Hospital in Rochester, NY. The grant, awarded on November 18, 2024, supports the development and evaluation of a novel lipoprotein fusion vaccine against nontypeable Haemophilus influenzae (NTHI) infections. The research aims to enhance antibody and T-cell mediated immunity against NTHI through...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research (CFDA 93.855) program, provides $705,557 to Emory University from December 20, 2024 to November 30, 2029. The project aims to advance understanding of the coordinated innate and cellular mucosal immune responses that contribute to SARS-CoV-2 viral clearance, particularly in the upper respiratory tract. Key objectives include determining the role of...
This federal Cooperative Agreement award, valued at $1,225,986.00, was granted by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The purpose of the award is to study the factors that determine a strong, durable, and broadly protective adaptive immune response to influenza vaccination, particularly in individuals with prior exposure to the virus. The University of Chicago, the awardee, will conduct a...
This Project Grant award, valued at $735,078, was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The award aims to unravel the molecular mechanisms of innate immune memory in humans, specifically focused on understanding the epigenetic changes and genetic factors underlying trained immunity in myeloid and lymphoid progenitor cells. The research will use single-cell gene expression and...
This federal Project Grant award of $785,511 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Chicago. The grant supports research to characterize inter-individual and inter-population variability in immune responses to infection with Mycobacterium tuberculosis and influenza viruses, study the contribution of epigenetic variation to this variability, and map quantitative...
This $146,922 federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 Allergy and Infectious Diseases Research program) to Emory University supports research to better understand factors that influence the efficiency of influenza A virus (IAV) infection. The project will use barcoded IAV libraries and guinea pig models to investigate how the mode of virus exposure (direct contact vs. airborne) and environmental conditions like temperature and...